EFTA00642436Set 9
2013-04-2121p13,686w
access to Tasigna, a leukemia drug, until Apotex threatened to sue. Another company,
Lundbeck, has so far declined to provide Apotex with samples of the drug Xenazine, which treats ... there are good reasons to restrict drugs to approved
pharmacies or health care providers. Lundbeck said it sells Xenazine, also known as tetrabenazine, to
a limited network of specialty pharmacies ... stock the productfor so small a patient populationfsaid Sally
Benjamin Young, a spokeswoman for Lundbeck. She said Lundbeck was seeking guidance on the issue
from regulators because
https://www.justice.gov/epstein/files/DataSet%209/EFTA00642436.pdf
EFTA02115859Set 10
2014-02-069p2,419w
line, guidance okay, focus on 2014 pipeline (trading -3.0%)
EFTA_R1_00742302
EFTA02115860
• Lundbeck Q4 revs light, EBITDA miss, maintains guidance, FX headwinds, Ebixa generics weighed
(trading -2.2%)
• Volvo
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02115859.pdf